
Eleven Therapeutics
Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.
About
Eleven Therapeutics is a biotechnology company focused on developing novel RNA-based therapeutics for rare genetic diseases. Founded by world-class scientists, the company leverages its proprietary platform to design and deliver targeted therapies. Eleven Therapeutics aims to address unmet medical needs in patients with debilitating genetic conditions.
Listed competitors
Show 6 more similar companies
Also in this space
Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
Shares Healthcare, Life Sciences
Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.
Shares Healthcare, Genomics
Precision oncology company developing cancer therapies guided by proprietary functional genomics.
Shares Healthcare, Genomics
Making targeted DNA sequencing as common, fast, and affordable as a blood test.
Shares Healthcare, Life Sciences
Develops a computational model of the human body for drug discovery and development.
Shares Healthcare, Drug Discovery
AI-driven drug discovery platform accelerating breakthrough scientific research.
Shares Healthcare, Drug Discovery
Signals agent
Reach companies that have budget right now
Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.
- Just raised a roundFresh budget, the week it lands
- Hiring sales and marketingGo-to-market roles mean money to spend
- Hiring fastA jump in open roles across the company
- In the newsLaunches and announcements worth a message
- The decision makerWho to contact, with a message you can edit
Is your startup an alternative to Eleven Therapeutics?
People comparing tools land here. Get listed beside these.
Copy Eleven Therapeutics's SEO strategy
How often they publish, which searches their posts chase and their newest posts. Then outrank them.
All funding rounds
Key facts
- Website
- scionxbio.com
- Headquarters
- London, United Kingdom
- Founded
- 2017
- Founders
- Shaul Ilan, Dr. David-Raphael Cohen
- Employees
- 28
- Total funding
- $22M (Seed)
- Business model
- B2B
Funding rounds
- $22M2 Aug 2022
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 2 Aug 2022 | Seed | $22M | Bill & Melinda Gates Foundation |
Tech stack
Detected on scionxbio.com, last scanned 17 Nov 2026. Run your own scan
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Email provider
- Google Workspace
- Hiring platform
- BambooHR
Benchmarking
See how your site ranks against 16,849 startups
Eleven Therapeutics sits in the 23rd percentile for Domain Rating. Check where yours lands, free.
Eleven Therapeutics has a Domain Rating of 16, the 23rd percentile of 16,849 startups we track.
Measured, not editorial
Ahrefs DR
Bottom 25%
Check yoursAgent Readiness
Below median
Scan yoursSite Speed
Below median
PageSpeedData Trust
Above median
Security
Click to scan
Agent Readiness
Can AI agents use your site?
Eleven Therapeutics scores 40. Check yours free in a few seconds, or let Max Agent rerun it daily.
Run it daily with Max AgentGet notified when Eleven Therapeutics changes
Used Eleven Therapeutics? Write a review and get $5 in credits
Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:
- Email finder
- Market Map Maker
- Agent Readiness scans
- Deep intel
- Tech stack scans
Frequently asked
Is Eleven Therapeutics hiring?
Yes. Eleven Therapeutics has 2 open roles right now. Most are based in Cambridge.
Who owns Eleven Therapeutics?
Eleven Therapeutics is privately held, owned by its founders and investors. Investors on record include Bill & Melinda Gates Foundation, Entrée Capital, Harel Insurance Investments and Financial Services and NFX. Exact stakes are not public.
Are there companies like Eleven Therapeutics?
Yes. We list 8 companies like Eleven Therapeutics, including Alnylam Pharmaceuticals, Moderna and Immunai.
Is Eleven Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Eleven Therapeutics is 69 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Eleven Therapeutics raised?
Eleven Therapeutics has raised a total of $22M in funding. The most recent round on record is Seed.
How many employees does Eleven Therapeutics have?
Eleven Therapeutics has approximately 28 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Eleven Therapeutics:
Company details: from public sources. Funding: 1 round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
Categories
Max Agent
Let Max Agent watch Eleven Therapeutics and its market for you
New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.
Free week
Starter listings, once
AI answers checked
Daily for 7 days
ChatGPT
Perplexity
Max Agent
$79 a month, or $9.99 with our badge on your site
AI answers checked
Every week
ChatGPT
Claude
Perplexity
Gemini


